Conditional allele deletions. C57BL/6J mice were obtained from the IGC animal facility. C57BL/6 Nrf2 -/mice (1) were obtained originally from the RIKEN BioResource Center (BRC: 01390, Koyadai, Tsukuba, Ibaraki, Japan) and maintained thereafter at the IGC animal facility. Mice were genotyped by PCR. C57BL/6 Pepck Cre/Wt mice (2, 3) were obtained originally from Anupam Agarwal (University of Alabama at Birmingham). Hmox1 floxed (Hmox1 fl/fl ) mice (4) were obtained originally from the Riken BRC experimental animal division (Japan) (http://mus.brc.riken.jp/en/link). Pepck Cre/Wt mice were crossed with Hmox1 fl/fl to generate Pepck Cre/Wt Hmox1 fl/fl (Hmox1 Pepckfl/fl ) mice and littermate control Hmox1 fl/fl mice. Conditional deletion of the Hmox1 fl/fl allele in RPTEC was induced at 8-week after birth by the addition of 0,3M NH 4 Cl to drinking water for one week, as described (2, 3). Hmox1 fl/fl deletion in the kidneys of Hmox1 PepckΔ/Δ mice was assessed by qRT-PCR. Hmox1 PepckΔ/Δ mice were used 4 weeks after exposure to acidified water. C57BL/6J Fth floxed (Fth fl/fl )(5) mice were obtained originally from Lukas Kuhn (Ecole Polytechnique Fédérale de Lausanne, Faculté des Sciences de la Vie, Institut Suisse de Recherche Expérimentale sur le Cancer). C57BL/6 Pepck Cre/Wt mice (2, 3) were crossed with Fth fl/fl to generate Pepck Cre/Wt Fth fl/fl (Fth Pepckfl/fl ) mice and littermate control Fth fl/fl mice. Conditional deletion of the Fth fl/fl allele in RPTEC was induced at 8-week after birth as described for Hmox1 deletion. Deletion of the Fth fl/fl allele in the kidneys of Fth PepckΔ/Δ mice was assessed by qRT-PCR. Fth PepckΔ/Δ mice were used 4 weeks after exposure to acidified water. C57BL/6 Mx1 Cre/Wt mice were obtained originally from the Jackson Laboratory (B6.Cg-Tg (Mx1-cre)1Cgn/J; #003556)(6) and Mx1 Cre/Wt Hmox1 fl/fl mice were generated from Mx1 Cre/Wt Hmox1 fl/fl x Hmox1 fl/fl breeding. Conditional gene deletion (Hmox1 Mx1Δ/Δ ) was achieved in 6-8 weeks old Hmox1 Mx1fl/fl mice by poly (I:C) (Invivogen, Toulouse, France) administration (i.p.; 1mg/kg body weight, 2x, 3 days apart). Hmox1 deletion was confirmed by qRT-PCR in whole blood from Hmox1 Mx1Δ/Δ mice, two weeks after the first poly (I:C) administration. Hmox1 Mx1Δ/Δ were used 8 weeks after the first poly (I:C) administration. Control Hmox1 fl/fl littermate mice received poly (I:C) at the same dosage and schedule. C57BL/6 R26 CreERT2 mice were obtained from the Jackson Laboratory (B6.129-Gt (ROSA)26Sor tm1 (cre/ERT2)Tyj /J, #008463)(7). R26 CreERT2/CreERT2 Hmox1 fl/fl (Hmox1 R26fl/fl ) mice were obtained from Hmox1 R26fl/fl x Hmox1 fl/fl breeding. Conditional gene deletion (Hmox1 R26Δ/Δ ) was achieved in 4-5 weeks old mice, fed ad libitum with Low 3 Phytoestrogen Diet (Harlan Laboratories; #2919.CS) for 2 weeks followed by administration of Tamoxifen (Sigma) suspended in sterile corn oil (Sigma) (gavage, 4.5mg per mouse, 1x every second day, 10x). Alternatively, Tamoxifen was provided by ad libitum intake of Rat/Mouse diet with Tamoxifen (M-Z, Low phytoestrogen; 360 mg/kg TAM Citrate + Sucrose flavour, 10mm Soybean free diet, sterilized 25 kGy; Ssniff Spezialdiäten GmbH) for 4 weeks. Hmox1 deletion was assessed by qRT-PCR in whole blood and Hmox1 R26Δ/Δ mice were used 8 weeks after the last Tamoxifen gavage or 6 weeks after removal of Tamoxifen enriched diet. Control Hmox1 fl/fl mice were treated with the same protocol. Hsf1 fl/fl mice were obtained originally from Elisabeth Christians (University Pierre et Marie Curie, Paris, France)(8) and were backcrossed into the C57BL/6 background at IGC. C57BL/6 Hsf1 fl/fl mice were bred with C57BL/6 R26 CreERT2 mice (7) to generate R26 CreERT2/CreERT2 Hsf1 fl/fl (Hsf1 R26fl/fl ) mice. These were maintained at the IGC from Hsf1 R26fl/fl x Hsf1 fl/fl breeding.
Detailed Material and Methods
Conditional allele deletions. C57BL/6J mice were obtained from the IGC animal facility. C57BL/6 Nrf2 -/mice (1) were obtained originally from the RIKEN BioResource Center (BRC: 01390, Koyadai, Tsukuba, Ibaraki, Japan) and maintained thereafter at the IGC animal facility. Mice were genotyped by PCR. C57BL/6 R26 CreERT2 mice were obtained from the Jackson Laboratory (B6.129-Gt (ROSA)26Sor tm1 (cre/ERT2)Tyj /J, #008463) (7) . R26 CreERT2/CreERT2 Hmox1 fl/fl (Hmox1 R26fl/fl ) mice were obtained from Hmox1 R26fl/fl x Hmox1 fl/fl breeding. Conditional gene deletion (Hmox1 R26Δ/Δ ) was achieved in 4-5 weeks old mice, fed ad libitum with Low Phytoestrogen Diet (Harlan Laboratories; #2919.CS) for 2 weeks followed by administration of Tamoxifen (Sigma) suspended in sterile corn oil (Sigma) (gavage, 4 .5mg per mouse, 1x every second day, 10x). Alternatively, Tamoxifen was provided by ad libitum intake of Rat/Mouse diet with Tamoxifen (M-Z, Low phytoestrogen; 360 mg/kg TAM Citrate + Sucrose flavour, 10mm Soybean free diet, sterilized 25 kGy; Ssniff Spezialdiäten GmbH) for 4 weeks. Hmox1 deletion was assessed by qRT-PCR in whole blood and Hmox1 R26Δ/Δ mice were used 8 weeks after the last Tamoxifen gavage or 6 weeks after removal of Tamoxifen enriched diet. Control Hmox1 fl/fl mice were treated with the same protocol. Hsf1 fl/fl mice were obtained originally from Elisabeth Christians (University Pierre et Marie Curie, Paris, France) (8) and were backcrossed into the C57BL/6 background at IGC. C57BL/6 Hsf1 fl/fl mice were bred with C57BL/6 R26 CreERT2 mice (7) to generate R26 CreERT2/CreERT2 Hsf1 fl/fl (Hsf1 R26fl/fl ) mice. These were maintained at the IGC from Hsf1 R26fl/fl x Hsf1 fl/fl breeding.
Conditional gene deletion (Hsf1 R26Δ/Δ ) was achieved in 4-5 weeks old mice by Tamoxifen (dissolved in corn oil, 5% Ethanol) administration (gavage, every second day, 3x; 225mg/kg of body weight). Hsf1 deletion was assessed by qRT-PCR in whole blood from in Hsf1 R26Δ/Δ mice (>95% deletion). Hif1α fl/fl mice (Jackson Laboratory; B6.129-Hif1α tm3Rsjo/J ; Stock No: 007561)(9) were bred with C57BL/6 R26 CreERT2 mice (7) to generate R26 CreERT2/CreERT2 Hif1α fl/fl (Hif1α R26fl/fl ) mice. These were maintained at the IGC from Hif1α R26fl/fl x Hif1α fl/fl breeding. Conditional gene deletion (Hif1α R26Δ/Δ ) was achieved and confirmed, as described for Hsf1 R26Δ/Δ mice (>95% deletion). C57BL/6 LysM Cre/Cre Hmox1 Δ/Δ (Hmox1 LysM1Δ/Δ ) mice were generated and assessed for Hmox1 deletion, essentially as described elsewhere (10) . C57BL/6
LysM Cre/Cre Fth Δ/Δ (Fth LysMΔ/Δ ) mice were generated, as described above for Hmox1 LysMΔ/Δ and deletion of the Fth allele was assessed, essentially as described elsewhere (10) . C57BL/6 Cd11c Cre/Wt were obtained from the Jackson Laboratory (B6.Cg-Tg (Itgax-cre)1-1Reiz/J, #008068) (11) and Cd11c Cre/Wt Hmox1 Δ/Δ (Hmox1 Cd11cΔ/Δ ) mice were obtained from Hmox1 Cd11cΔ/Δ x Hmox1 fl/fl breeding. Hmox1 fl/fl littermates were used as controls. Hmox1 deletion in Hmox1 Cd11cΔ/Δ mice was assessed by qRT-PCR in CD11c + cells isolated from spleens and purified using anti-CD11c + microbeads (MACS ® ; Miltenyi Biotec) followed by fluorescence activated cell sorting (FACS) in a MoFlo cell sorter (Beackam Coulter), based on CD11c + and MHCII + and TCRα/β -, IgMand CD19expression. C57BL/6 Alb Cre/Wt were obtained from the Jackson Laboratory (B6.Cg-Tg (Albcre)21Mgn/J, #003574) (12) and Alb Cre/Wt Fth Δ/Δ (Fth AlbΔ/Δ ) mice were generated from Fth AlbΔ/Δ x Fth fl/fl breeding. Fth fl/fl littermates were used as controls. Deletion of the Fth allele was assessed in the liver, by qRT-PCR, as described elsewhere (13) . C57BL/6 Tie2 Cre/Wt were obtained from the Jackson Laboratory (B6.Cg-Tg (Tekcre)1Ywa/J, #008863) (14) . Tie2 Cre/Wt Hmox1 Δ/Δ (Hmox1 Tie2Δ/Δ ) mice were generated from Hmox1 Tie2Δ/Δ x Hmox1 fl/fl breeding and Hmox1 fl/fl littermates were used as controls. Hmox1 deletion was assessed by qRT-PCR in heart-derived endothelial cells purified using CD31 Microbeads (MACS ® Technology; Miltenyi Biotec) and in the spleen. C57BL/6 Nestin Cre/Wt mice were obtained originally from the Jackson Laboratory (B6.Cg-Tg (Nes-cre)1Kln/J, #003771) (15) . Nestin Cre/Wt Hmox1 Δ/Δ (Hmox1 NestinΔ/Δ ) mice were generated from Hmox1 NestinΔ/Δ x Hmox1 fl/fl breeding. Hmox1 fl/fl littermate mice were used as controls. Hmox1 deletion was assessed by qRT-PCR in the brain and spinal cord. qRT-PCR. Mice were sacrificed, perfused in toto with 10mL 1xPBS, and organs were harvested and snapped frozen in liquid nitrogen. RNA was isolated from mouse organs using TRIzol (Invitrogen Life Technologies) and the RNeasy Mini Kit (QIAGEN), from blood using the NucleoSpin® RNA Blood (Machery-Nagel) and from cell suspension using the NucleoSpin® RNA XS (Machery-Nagel). Total RNA was Absorbance was measured in a microplate reader at λ 440nm (Victor3, PerkinElmer).
Heme concentration in plasma and urine was determined based on the calibration curve performed with serial heme concentrations (0.0625-4 µM) and normalized to the total amount of protein as determined using Bradford Protein Assay (Bio-Rad).
ELISA.
Mice were sacrificed at the indicated time-points after Plasmodium infection.
Plasma was obtained from blood after 2 consecutive centrifugations (1600g, 5min, 4ºC). Lipocalin 2 concentration in plasma and urine were determined by ELISA (LEGEND MAX™ Mouse NGAL; Lipocalin-2 ELISA Kit with Pre-coated Plates, Biolegend), according to the manufacturer's instructions. Briefly, plasma and urine samples were diluted and incubated with plates pre-coated with a mouse anti-human NGAL monoclonal antibody (mAb) followed by incubation with a biotinylated antihuman NGAL mAb detection antibody. Detection was based on an Avidin-HRP chromogenic reaction, and absorbance was measured at λ 450nm and λ 570nm for background subtraction, in a Victor3 microplate reader (PerkinElmer). Cystatin C concentration in plasma was determined by ELISA (Mouse/Rat Cystatin C Quantikine ELISA Kit, R&D Systems), according to the manufacturer's instructions.
Briefly, plasma samples were diluted and incubated with plates pre-coated with a polyclonal antibody specific for mouse/rat Cystatin C, followed by incubation with a HRP-conjugated mouse/rat Cystatin C-specific polyclonal antibody. Detection was based on an HRP-based chromogenic reaction, and absorbances were read at λ 450nm and λ 570nm for background subtraction, in a Victor3 microplate reader (PerkinElmer). washing thoroughly with PBS, cells were exposed to vehicle (HBSS medium without serum) or heme (5µM; 60 min). After removal of heme, cells were exposed to H 2 O 2 in DMEM media (50µM) and fluorescence intensity was measured immediately applying λ 488nm excitation and λ 533nm emission wavelengths (every 30 minutes for 3h). Monocytes (x10 3 /µL) 1,00 ± 0,37 0,83 ± 0,30 1,92 ± 1,94 0,57 ± 0,12
Histopathology
Neutrophils (x10 3 /µL) 0,81 ± 0,30 1,28 ± 0,50 5,52 ± 3,24 a 8,70 ± 1,47 b Eosinophils (x10 3 /µL) 0,24 ± 0,05 0,23 ± 0,13 0,28 ± 0,33 0,47 ± 0,12
Basophils (x10 3 /µL) 0,17 ± 0,05 0,10 ± 0,08 0,38 ± 0,37 0,13 ± 0,06 Total Bilirubin (mg/dL) 0,28 ± 0,03 0,28 ± 0,11 0,75 ± 0,25 a 0,61 ± 0,04 b
Direct Bilirubin (mg/dL) 0,14 ± 0,02 0,14 ± 0,05 0,37 ± 0,09 a 0,43 ± 0,04 b
Indirect Bilirubin (mg/dL) 0,14 ± 0,02 0,14 ± 0,07 0,38 ± 0,16 a 0,18 ± 0,05 c 
